BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/7/2015 9:38:00 AM | Browse: 12843 | Download: 2158
 |
Received |
|
2014-06-17 20:23 |
 |
Peer-Review Started |
|
2014-06-18 08:52 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-08-19 13:30 |
 |
Revised |
|
2014-09-03 14:25 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-10-10 18:00 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-10-10 18:12 |
 |
Articles in Press |
|
2014-10-10 18:12 |
 |
Edit the Manuscript by Language Editor |
|
2014-10-14 04:24 |
 |
Typeset the Manuscript |
|
2015-01-10 18:16 |
 |
Publish the Manuscript Online |
|
2015-02-07 09:38 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Minireviews |
| Article Title |
Role of β2-microglobulin in uremic patients may be greater than originally suspected
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aysegul Zumrutdal |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Aysegul Zumrutdal, MD, Professor, Nephrology Department, Baskent University Adana Teaching and Research Center, Baskent University Hospital, Yuregir, Dadaloglu Mah, 2591 St, 4/A, Adana 01230,
Turkey. azumrutdal@yahoo.com
|
| Key Words |
Beta2-microglobulin; Carotid atherosclerosis; Cardiovascular disease; Cardiovascular risk; Coronary artery disease; Hemodialysis; Mortality; Uremia; Uremic toxins |
| Core Tip |
Previously, the clinical significance of beta2-microglobulin (β2M) in uremic patients was limited to β2M-derived amyloidosis; in recent years, its role and power has changed and expanded. Although there have been some inconsistencies among the various analyses relating to β2M, the data generally support β2M as a promising novel marker of kidney function by predicting cardiovascular (CV) risk, CV events and overall mortality.
|
| Publish Date |
2015-02-07 09:38 |
| Citation |
Zumrutdal A. Role of β2-microglobulin in uremic patients may be greater than originally suspected. World J Nephrol 2015; 4(1): 98-104 |
| URL |
http://www.wjgnet.com/2220-6124/full/v4/i1/98.htm |
| DOI |
http://dx.doi.org/10.5527/wjn.v4.i1.98 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.